FCA
ONC

FinTrust Capital Advisors’s BeOne Medicines Ltd ONC Stock Holding History

FinTrust Capital Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.42K Hold
6
– – ﹤0.01% 1252
2024
Q2 		$904 Hold
6
– – ﹤0.01% 1267
2024
Q1 		$991 Hold
6
– – ﹤0.01% 1168
2023
Q4 		$1.14K Hold
6
– – ﹤0.01% 1128
2023
Q3 		$1.14K Buy
+6
New +$1.19K ﹤0.01% 1096

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FinTrust Capital Advisors's ONC Position: Q3 2024 in Review

FinTrust Capital Advisors held its BeOne Medicines Ltd (ONC) position steady in Q3 2024 at 6 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

FinTrust Capital Advisors first reported a position in ONC in Q3 2023 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • FinTrust Capital Advisors held 6 shares of BeOne Medicines Ltd worth $1.42K as of Q3 2024.
  • FinTrust Capital Advisors left its BeOne Medicines Ltd share count unchanged in Q3 2024.
  • BeOne Medicines Ltd made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1252 holding.
  • FinTrust Capital Advisors first reported a position in BeOne Medicines Ltd in Q3 2023 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.